Molecular basis of group A streptococcal pyrogenic exotoxin B

Journal of Infection and Chemotherapy

Volumn 11, Issue 1, 2005, Pages 1-8

  Nagamune, Hideaki ^a   Ohkura, Kazuto ^b   Ohkuni, Hisashi ^c  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c Medeca Japan Laboratory Co Ltd   (Japan)

Author keywords

Cysteine protease; Exotoxin B; Streptococcus pyrogenes; Toxic shock like syndrome; Virulent factor

Indexed keywords

BACTERIAL PROTEIN; ENDOTOXIN; VIRULENCE FACTOR;

BACTERIAL GENE; GENOME; HUMAN; IMMUNIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN STRUCTURE; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; T LYMPHOCYTE ACTIVATION;

EID: 15044355967     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0354-y     Document Type: Review

References (61)

1. Bisno AL, Stevens DL. Streptococcal infection of skin and soft tissue. N Engl J Med 1996;334:240-5.
2. Roggiani M, Assimacopoulos AP, Schlivert PM. Exotoxins of Streptococcus pyogenes. In: Stevens DL, Kaplan EL, editors. Streptococcal infections. New York: Oxford University Press; 2000. p. 57-75.
3. Kagawa TF, Cooney JC, Baker HM, McSweeney S, Liu M, Gubba S, et al. Crystal structure of the zymogen form of the group A Streptococcus virulence factor B: an integrin-binding cysteine protease. PNAS 2000;97:2235-40.
4. Podbielski A, Woischnik M, Pohl B, Schmidt KH. What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factors. Med Microbiol Immunol 1996;185:171-81.
5. Lyon WR, Gibson CM, Caparon MG. A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J 1998;17:6263-75.
6. Chaussee MS, Ajdic D, Ferretti JJ. The rgg gene of Streptococcus pyogenes NZ 131 positively influences extracellular SPE B production. Infect Immun 1999;67:1715-22.
7. Collin M, Olsen A. generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 2000;36:1306-18.
8. Kapur V, Majesky MW, Li L-L, Black RA, Musser JM. Cleavage of interleukin-1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. PNAS 1993;90:7676-80.
9. Kapur V, Topouzis S, Majesky MW, Li L-L, Hamrick MR, Hamill RJ, et al. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degradates vitronectin. Microb Pathog 1993;15:327-46.
10. Herwald H, Collin M, Muller-Esterl W, Bjorck L. Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism. J Exp Med 1996;184:665-73.
11. Schmidtchen A, Frick L-M, Bjorck I. Dermatan sulphate is released by proteinase of common pathogenic bacteria and inactivates antibacterial α-defensin. Mol Microbiol 2001;39:708-13.
12. Schmidtchen A, Frick I, Anderson E, Tapper H, Bjorck I. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 2002;46:157-68.
13. Watanabe Y, Todome Y, Ohkuni H, Sakurada S, Ishikawa T, Yutsudo T, et al. Cysteine protease activity and histamine release from the human mast cell HMC-1 stimulated by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine protease. Infect Immun 2002;70:3944-7.
14. Ohkuni H, Todome Y, Watanabe Y, Ishikawa T, Takahashi H, Kannari Y, et al. Studies of recombinant streptococcal pyrogenic exotoxin B/cysteine protease (rSPE B/SCP) in the skin of guinea gigs and the release of histamine from cultured mast cells and basophilic leukocytes. I J Med Res 2004;119 Suppl:33-6.
15. Wolf BB, Gibson CA, Kapur V, Hussaini IM, Musser JM, Gonias SL. Proteolytically active streptococcal pyogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J Biol Chem 1994; 269:30682-7.
16. Pinkney M, Kapur V, Smith J, Weller U, Palmer M, Glanville M, et al. Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage of streptococcal cysteine protease. Infect Immun 1995;63: 2776-9.
17. Tamura F, Nakagawa R, Akuta T, Okamoto S, Hamada S, Maeda H, et al. Proapoptotic effect of proteolytic activation of matrix metalloproteinase by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B). Infect Immun 2004;72:4836-47.
18. Hytonen J, Haataja S, Isomaki P, Finne J. Identification of a novel glycoprotein-binding activity in Streptococcus pyogenes regulated by the mag gene. Microbiol 2000;146:31-9.
19. Hytonen J, Haataja S, Gerlach D, Podbieski A, Finne J. The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity. Mol Microbiol 2001;39:512-19.
20. Eriksson A, Norgren M. The superantigenic activity of streptococcal pyrogenic exotoxin B is independent of the protease activity. FEMS Immunol Med Microbiol 1999;25:355-63.
21. Elliott SD. A proteolytic enzyme produced by group A streptococci with special reference to its effect on the type-specific M antigen. J Exp Med 1945;81:573-92.
22. Collin M, Olsen A. Endo S, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 2001;20:3046-53.
23. Burton DR. Immunoglobulin G: functional sites. Mol Microbiol 1985;22:161-206.
24. Collin M, Olsen A. Effect of SpeB and EndoS from Streptococcus pvogenes on human immunoglobulins. Infect Immun 2001;69: 7187-9.
25. 24a. Collin M, Olsen A. Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 2003;71:2983-92.
26. Collin M, Svensson MD, Sjoholm AG, Jensenius JC, Sjobring U, Olsen A. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 2002;12:6646-51.
27. Eriksson A, Norgren M. Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun 2003;71:211-17.
28. Von Pawel-Rammingen U, Johanson BP, Bjorck L. Ide S, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 2002;21:1607-15.
29. Lukomski S, Sreevatsan S, Amberg A, Reichardt W, Woischnik M, Podbieski A, et al. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 1997;99:2574-80.
30. Shanley TP, Schrier D, Kapur V, Kehoe M, Musser JM, Ward PA. Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun 1996;64:870-7.
31. Tsai P-J, Kuo C-F, Lin K-Y, Lei H-Y, Chen F-F, Wang J-R, et al. Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun 1998;66:1460-6.
32. Kapur V, Maffei JT, Greer RS, Li LL, Agams GJ, Musser JM. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog 1994;16:443-50.
33. Holm SE, Norrby A, Bergholm A-M, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden. J Infect Dis 1992;166:31-7.
34. Barsumian EL, Schlievert PM, Watson DW. Nonspecific and specific immunologic mitogenicity by group A streptococcal pyogenic exotoxins. Infect Immun 1978;22:681-8.
35. Bohach GA, Hauser AR, Schlievert PM. Cloning of the gene speB for streptococcal pyogenic exotoxin type B in Escherichia coli. Infect Immun 1988;56:1665-7.
36. Cunningham CM, Barsumian EL, Watson DW. Further purification of group A streptococcal pyogenic exotoxin and characterization of the purified toxin. Infect Immun 1976;14:767-75.
37. Gerlach D, Kohler W, Knoll H. Comparison of erythrogenic toxins produced by Streptococcus pyogenes. In: Holm SE, Christensen P, editors. Basic concepts of streptococci and streptococcal diseases. Windsor, UK: Reed; 1982. p. 137-8.
38. Watson DW. Characterization and pathobiological properties of group A streptococcal pyogenic exotoxins. In: Parker MT, editor. Pathogenic streptococci. Windsor, UK: Reed; 1979. p. 62-3.
39. Gerlach D, Knoll H, Kohler W, Ozegowski JH, Hribalova V. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bacteriol Parasitenkd Infectionskr Hyg Abt 1 Orig Reihe A 1983;255:221-33.
40. Hauser AR, Schlievert PM. Nucleotide sequence of the streptococcal pyogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol 1990; 172:4536-42.
41. Ferretti JJ, McShan WM, Adjic D, Savic D, Savic G, Lyon K, et al. Complete genome sequence of an M1 strain of Strepotococcus pyogenes. Proc Natl Acad Sci USA 2001;98:4658-63.
42. Nakagawa I, Kurokawa K, Nakata M, Tomiyasu Y, Yamashita A, Yamazaki K, et al. The genome of invasive Streptococcus pyogenes; a comparative analysis of S. pyogenes SSI-1, SF370 and MGAS8232. NCBI Genome Project 2004.
43. Yu C-E, Ferretti JJ. Frequency of the erythrogenic toxin B and C gene (speB and speC) among clinical isolates of group A streptococci. Infect Immun 1991;59:211-15.
44. Tyler SD, Johnson WM, Huang JC, Ashton FE, Wang G, Low DE, et al. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J Clin Microbiol 1992;30: 3127-31.
45. Doran JD, Nomizu M, Takebe S, Menard R, Griffith D, Ziomek E. Autocatalytic processing of the streptococcal cysteine protease zymogen. Eur J Biochem 1999;263:145-51.
46. Nomizu M, Pietrzynski G, Kato T, Lachance P, Menard R, Ziomek E. Substrate specificity of the streptococcal cysteine protease. J Biol Chem 2001;276:44551-6.
47. Berti PJ, Storer AC. Alignment/phylogeny of the papain superfamily of cysteine proteases. J Mol Biol 1995;246:273-83.
48. Musser JM, Stockbauer K, Kapur V, Rudgers GW. Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin-1β convertase) alters proteolytic activity and ablates zymogen processing. Infect Immun 1996;64:1913-17.
49. Gubba S, Cipriano V, Musser JM. Replacement of histidine 340 with alanine inactivates the group A streptococcal extracellular cysteine protease virulence factor. Infect Immun 2000;68:3716-19.
50. 3. Proc Natl Acad Sci USA 1999;96:242-7.
51. Heath A, Dirita VJ, Barg NL, Engleberg NC. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyogenic exotoxin B. Infect Immun 1999; 67:5298-305.
52. Vickerman MM, Sulavik MC, Nowak JD, Gardner NM, Jones GW, Clewell DB. Nucleotide sequence analysis of the Streptococcus gordonii glucosyltransferase gene, gtfG. DNA Seq 1997;7:83-95.
53. Sanders JW, Leenhouts K, Burghoorn J, Brands JR, Venema G, Kok J. A chloride-inducible acid resistance mechanism in Lactococcus lactis and its regulation. Mol Microbiol 1998;27:299-310.
54. Neely MN, Lyon WR, Runft DL, Caparon M. Role of RopB in growth-phase expression of the SpeB cysteine protease of Streptococcus pyogenes. J Bacteriol 2003;185:5166-74.
55. Podbielski A, Pohl B, Woischnik M, Körner C, Schmidt KH, Rozdzinski E, et al. Molecular characterization of group A streptococcal (GAS) oligopeptide permease (Opp) and its effect on cysteine protease production. Mol Microbiol 1996;21:1087-99.
56. Podbielski A, Leonard BAB. The group A streptococcal dipeptide permease (Dpp) is involved in the uptake of essential amino acids and affects the expression of cysteine protease. Mol Microbiol 1998;28:1323-34.
57. Li Z, Sledjeski DD, Kreikemeyer B, Podbielski A, Boyle MDP. Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol 1999;181:6019-27.
58. Molinari G, Rohde M, Talay SR, Chhatwal GS, Beckert S, Podbielski A. The role played by the group A streptococcal negative regulator Nra on bacterial interactions with epithelial cells. Mol Microbiol 2001;40:99-114.
59. Lyon WR, Caparon MG. Role for serine protease HtrA (DegP) of Streptococcus pyogenes in the biogenesis of virulence factors SpeB and the hemolysin streptolysin S. Infect Immun 2004;72:1618-25.
60. Spiess C, Beil A, Ehrmann M. A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 1999;97:339-47.
61. Lyon WR, Madden JC, Levin JC, Stein JL, Caparon MG. Mutation of luxS affects growth and virulence factor expression in Streptococcus pyogenes. Mol Microbiol 2001;42:145-57.